Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Companion Animal Pharmaceuticals Global Market Report 2025
Request Sample Buy Now
Global Companion Animal Pharmaceuticals Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Companion Animal Pharmaceuticals Global Market Report 2025

By Animal Type (Dogs, Cats, Horses, Other Companion Animals ), By Indication (Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications ), By Distribution Channels (Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies ) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Companion Animal Pharmaceuticals Market Overview

• Companion Animal Pharmaceuticals market size has reached to $16.49 billion in 2024

• Expected to grow to $26.34 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%

• Growth Driver: Growing Prevalence Of Zoonotic Diseases Fuels Growth Of Companion Animal Pharmaceuticals Market

• Market Trend: Big Data Transforms The Companion Animal Pharmaceutical Market

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Companion Animal Pharmaceuticals Market?

Companion animal pharmaceuticals refer to the pharmaceutical medication process in which animal pharmacists insist on medications, fill prescriptions, and manage drug therapies for animals. It is used in the diagnosis, mitigation, and treatment of different animal diseases.

The main types of companion animal pharmaceuticals are dogs, cats, horses, and other companion animals. Dogs refer to a highly variable carnivorous domesticated mammal of the genus closely related to the common wolf. The indications are infectious diseases, dermatologic diseases, pain, orthopedic diseases, behavioral diseases, and other indications, which are sold through multiple distribution channels, involved veterinary hospitals, veterinary clinics, and retail pharmacies.

Companion Animal Pharmaceuticals Market Size and growth rate 2025 to 2029: Graph

What Is The Companion Animal Pharmaceuticals Market Size 2025 And Growth Rate?

The companion animal pharmaceuticals market size has grown strongly in recent years. It will grow from $16.49 billion in 2024 to $17.85 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to humanization of pets, preventive healthcare measures, rise in pet insurance, changing lifestyle and urbanization, zoonotic disease concerns, zoonotic disease concerns, veterinary healthcare accessibility.

What Is The Companion Animal Pharmaceuticals Market Growth Forecast?

The companion animal pharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $26.34 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to personalized medicine for pets, telehealth and remote veterinary services, focus on nutrition and nutraceuticals, one health initiatives, expansion of veterinary diagnostic services. Major trends in the forecast period include advancements in veterinary medicine, specialized therapeutics for aging pets, regulatory compliance and safety standards, collaborations and partnerships.

The forecast of 10.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Levies on finished veterinary drugs shipped from the UK and Canada will dampen price competition and reduce generic availability. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Veterinary Healthcare Industry?

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are significantly impacting the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care equipment. Higher duties on imported veterinary drugs, diagnostic tools, surgical instruments, and pet care products have increased operational costs for veterinary clinics, animal hospitals, and livestock care providers, forcing them to raise service fees or absorb shrinking margins. Livestock and agricultural sectors face similar challenges, with tariffs on feed additives, vaccines, and breeding equipment driving up production costs and affecting animal health management. Additionally, retaliatory tariffs in key export markets have reduced demand for U.S.-produced veterinary products, further straining industry revenues. The sector must now prioritize local sourcing, preventive care solutions, and digital health innovations to mitigate rising costs while maintaining high standards of animal care.

How Is The Companion Animal Pharmaceuticals Market Segmented?

1) By Animal Type: Dogs, Cats, Horses, Other Companion Animals

2) By Indication: Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications

3) By Distribution Channels: Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies

Subsegments:

1)By Dogs: Vaccines, Antiparasitic, Anti-Inflammatory Drugs

2) By Cats: Vaccines, Antiparasitic, Anti-Inflammatory Drugs

3) By Horses: Vaccines, Antiparasitic, Anti-Inflammatory Drugs

4) By Other Companion Animals: Vaccines, Antiparasitic, Other Therapeutics

What Is Driving The Companion Animal Pharmaceuticals Market? Growing Prevalence Of Zoonotic Diseases Fuels Growth Of Companion Animal Pharmaceuticals Market

The growing prevalence of zoonotic diseases is expected to propel the growth of the companion animal pharmaceuticals market going forward. A zoonotic illness is a disease that can be naturally transferred from vertebrate animals to humans or from people to vertebrate animals. The pharmaceutical industry is embracing modern tactics and strategies that are consistent with one set of health principles in order to combat zoonotic illnesses and lower the likelihood of transmission. For instance, in December 2022, according to a report published by the European Centre for Disease Prevention and Control, a Sweden-based government agency, Campylobacteriosis remains the most prevalent zoonosis, with a notable rise in reported cases to 127,840 in 2022. Chicken and turkey meat accounted for the majority of reported Campylobacteriosis cases. Salmonella, the second most common zoonosis, infected 60,050 individuals. Following Campylobacteriosis and Salmonellosis, Yersiniosis (6,789 cases), Shigatoxin-producing E. coli infections (6,084 cases), and Listeriosis (2,183 cases) were the most frequently reported zoonotic diseases. Therefore, the growing prevalence of zoonotic diseases is driving the growth of the companion animal pharmaceuticals industry.

What Is Driving The Companion Animal Pharmaceuticals Market? Increased Pet Ownership Is Fueling The Growth Of The Companion Animal Pharmaceutical Market

Increasing pet ownership is expected to boost the growth of the companion animal pharmaceutical market going forward. Pet ownership refers to the relationship between a human and an animal in which the human assumes responsibility for the animal's care and well-being. Growth in the market is fueled by an increasing number of people owning pets and an increased understanding of the value of companion animal disease prevention, diagnosis, and treatment. For instance, in October 2022, according to a report published by the American Veterinary Medical Association, a US-based non-profit organization, there was a 29% increase in the proportion of families with at least one cat in 2022. For households with one dog, the cost of veterinarian services rose to $362 annually in 2022. In 2022, the average yearly cost of veterinary visits for households with cats was $321. Therefore, the increasing pet ownership is driving the growth of the companion animal pharmaceutical industry.

Who Are The Major Players In The Global Companion Animal Pharmaceuticals Market?

Major companies operating in the companion animal pharmaceuticals market are Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Chanelle Pharma, Eco Animal Health Group PLC, Ashish Life Science Pvt. Ltd., Endovac Animal Health, Hipra Laboratories, Indian Immunologicals Ltd., Inovet Group, Kyoritsu Seiyaku Corporation, Lutim Pharma Pvt. Ltd., Merck & Co. Inc., Norbrook Laboratories Ltd., Tianjin Ringpu Bio-Technology Co. Ltd., Vetoquinol S.A., Virbac S.A., Zoetis Inc., Agrolabo S.p.A., ALS Pvt. Ltd., Zydus Animal Health and Investments Limited, Eli Lilly and Company, IDEXX Laboratories Inc., Merial Limited, Novartis Animal Health Inc., Dechra Pharmaceuticals PLC, Aratana Therapeutics Inc., Phibro Animal Health Corporation, Kindred Biosciences Inc., Jaguar Health Inc., Nexvet Biopharma PLC, Sentinel Biomedical Inc., PetMed Express Inc., Neogen Corporation, Heska Corporation, Synbiotics Corporation, Eurovet Animal Health B.V., Vironova AB, Abaxis Inc., Bioiberica S.A.U., Putney Inc., Lohmann Animal Health International

What Are The Key Trends Of The Global Companion Animal Pharmaceuticals Market? Big Data Transforms The Companion Animal Pharmaceutical Market

Embracing big data technologies is a key trend gaining popularity in the companion animal pharmaceuticals. Major companies operating in the companion animal pharmaceuticals market are focused on developing new technological solutions to strengthen their position. For Instance, in April 2022, Elanco Animal Health Incorporated, a US-based company operating in companion animal pharmaceuticals, and Ginkgo Bioworks, a US-based company operating in companion animal pharmaceuticals launched BiomEdit, a microbiome innovation company for creating innovation in animal health. This will provide novel probiotics and other related animal pharmaceuticals for animal health innovation, such as medicated feed ingredients, nutritional health and therapies for livestock and pet animals, and biosecurity technologies for animal illness monitoring.

What Are The Key Trends Of The Global Companion Animal Pharmaceuticals Market? Innovation Product Launches To Meet The Demand

Major companies operating in the companion animal pharmaceutical market are launching innovative products, such as oral flea and tick products, to meet larger customer bases, more sales, and increase revenue. Oral flea and tick products refer to medications that are given by mouth to prevent or treat flea and tick infestations in pets. For instance in October 2024, Elanco Animal Health Incorporated, a US-based pharmaceutical company, announced FDA approval for Credelio Quattro, a new chewable parasiticide designed for dogs. This product offers monthly protection against six types of parasites, including fleas, ticks, and several internal worms. With Credelio Quattro, Elanco aims to provide a convenient, comprehensive solution for pet owners seeking broad-spectrum parasite control. This launch highlights Elanco's commitment to meeting the growing demand for innovative and effective pet health solutions.

Need data on a specific region in this market?
Request Customisation

Companion Animal Pharmaceuticals Market Merger And Acquisition: Dechra Pharmaceuticals Acquired Piedmont Animal Health

In July 2022, Dechra Pharmaceuticals, a UK-based pharmaceutical company, acquired Piedmont Animal Health for $210 million. Through this acquisition, Dechra will deliver more complementary goods for the European and North American markets and improve its scientific and regulatory skills. Piedmont Animal Health is a US-based companion animal pharmaceutical company.

Regional Outlook For The Global Companion Animal Pharmaceuticals Market

North America was the largest region in the companion animal pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the companion animal pharmaceuticals market report during the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Companion Animal Pharmaceuticals Market?

The companion animal pharmaceuticals market includes revenues earned by entities by providing veterinary pharmaceuticals, vaccines, and health management tools. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Companion Animal Pharmaceuticals Industry?

The companion animal pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the companion animal pharmaceuticals industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Companion Animal Pharmaceuticals Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $17.85 billion
Revenue Forecast In 2034 $26.34 billion
Growth Rate CAGR of 10.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Animal Type: Dogs, Cats, Horses, Other Companion Animals
2) By Indication: Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications
3) By Distribution Channels: Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies Subsegments: 1)By Dogs: Vaccines, Antiparasitic, Anti-Inflammatory Drugs
2) By Cats: Vaccines, Antiparasitic, Anti-Inflammatory Drugs
3) By Horses: Vaccines, Antiparasitic, Anti-Inflammatory Drugs
4) By Other Companion Animals: Vaccines, Antiparasitic, Other Therapeutics
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Chanelle Pharma, Eco Animal Health Group PLC, Ashish Life Science Pvt. Ltd., Endovac Animal Health, Hipra Laboratories, Indian Immunologicals Ltd., Inovet Group, Kyoritsu Seiyaku Corporation, Lutim Pharma Pvt. Ltd., Merck & Co. Inc., Norbrook Laboratories Ltd., Tianjin Ringpu Bio-Technology Co. Ltd., Vetoquinol S.A., Virbac S.A., Zoetis Inc., Agrolabo S.p.A., ALS Pvt. Ltd., Zydus Animal Health and Investments Limited, Eli Lilly and Company, IDEXX Laboratories Inc., Merial Limited, Novartis Animal Health Inc., Dechra Pharmaceuticals PLC, Aratana Therapeutics Inc., Phibro Animal Health Corporation, Kindred Biosciences Inc., Jaguar Health Inc., Nexvet Biopharma PLC, Sentinel Biomedical Inc., PetMed Express Inc., Neogen Corporation, Heska Corporation, Synbiotics Corporation, Eurovet Animal Health B.V., Vironova AB, Abaxis Inc., Bioiberica S.A.U., Putney Inc., Lohmann Animal Health International
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Companion Animal Pharmaceuticals Market Characteristics

3. Companion Animal Pharmaceuticals Market Trends And Strategies

4. Companion Animal Pharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Companion Animal Pharmaceuticals Growth Analysis And Strategic Analysis Framework

5.1. Global Companion Animal Pharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Companion Animal Pharmaceuticals Market Growth Rate Analysis

5.4. Global Companion Animal Pharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Companion Animal Pharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Companion Animal Pharmaceuticals Total Addressable Market (TAM)

6. Companion Animal Pharmaceuticals Market Segmentation

6.1. Global Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dogs

Cats

Horses

Other Companion Animals

6.2. Global Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Infectious Diseases

Dermatologic Diseases

Pain

Orthopedic Diseases

Behavioral Diseases

Other Indications

6.3. Global Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Veterinary Hospitals

Veterinary Clinics

Retail Pharmacies

6.4. Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Dogs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vaccines

Antiparasitic

Anti-Inflammatory Drugs

6.5. Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Cats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vaccines

Antiparasitic

Anti-Inflammatory Drugs

6.6. Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Horses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vaccines

Antiparasitic

Anti-Inflammatory Drugs

6.7. Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Other Companion Animals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vaccines

Antiparasitic

Other Therapeutics

7. Companion Animal Pharmaceuticals Market Regional And Country Analysis

7.1. Global Companion Animal Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Companion Animal Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Companion Animal Pharmaceuticals Market

8.1. Asia-Pacific Companion Animal Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Companion Animal Pharmaceuticals Market

9.1. China Companion Animal Pharmaceuticals Market Overview

9.2. China Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Companion Animal Pharmaceuticals Market

10.1. India Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Companion Animal Pharmaceuticals Market

11.1. Japan Companion Animal Pharmaceuticals Market Overview

11.2. Japan Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Companion Animal Pharmaceuticals Market

12.1. Australia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Companion Animal Pharmaceuticals Market

13.1. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Companion Animal Pharmaceuticals Market

14.1. South Korea Companion Animal Pharmaceuticals Market Overview

14.2. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Companion Animal Pharmaceuticals Market

15.1. Western Europe Companion Animal Pharmaceuticals Market Overview

15.2. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Companion Animal Pharmaceuticals Market

16.1. UK Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Companion Animal Pharmaceuticals Market

17.1. Germany Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Companion Animal Pharmaceuticals Market

18.1. France Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Companion Animal Pharmaceuticals Market

19.1. Italy Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Companion Animal Pharmaceuticals Market

20.1. Spain Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Companion Animal Pharmaceuticals Market

21.1. Eastern Europe Companion Animal Pharmaceuticals Market Overview

21.2. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Companion Animal Pharmaceuticals Market

22.1. Russia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Companion Animal Pharmaceuticals Market

23.1. North America Companion Animal Pharmaceuticals Market Overview

23.2. North America Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Companion Animal Pharmaceuticals Market

24.1. USA Companion Animal Pharmaceuticals Market Overview

24.2. USA Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Companion Animal Pharmaceuticals Market

25.1. Canada Companion Animal Pharmaceuticals Market Overview

25.2. Canada Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Companion Animal Pharmaceuticals Market

26.1. South America Companion Animal Pharmaceuticals Market Overview

26.2. South America Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Companion Animal Pharmaceuticals Market

27.1. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Companion Animal Pharmaceuticals Market

28.1. Middle East Companion Animal Pharmaceuticals Market Overview

28.2. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Companion Animal Pharmaceuticals Market

29.1. Africa Companion Animal Pharmaceuticals Market Overview

29.2. Africa Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Companion Animal Pharmaceuticals Market Competitive Landscape And Company Profiles

30.1. Companion Animal Pharmaceuticals Market Competitive Landscape

30.2. Companion Animal Pharmaceuticals Market Company Profiles

30.2.1. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Ceva Santé Animale Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Chanelle Pharma Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Eco Animal Health Group PLC Overview, Products and Services, Strategy and Financial Analysis

31. Companion Animal Pharmaceuticals Market Other Major And Innovative Companies

31.1. Ashish Life Science Pvt. Ltd.

31.2. Endovac Animal Health

31.3. Hipra Laboratories

31.4. Indian Immunologicals Ltd.

31.5. Inovet Group

31.6. Kyoritsu Seiyaku Corporation

31.7. Lutim Pharma Pvt. Ltd.

31.8. Merck & Co. Inc.

31.9. Norbrook Laboratories Ltd.

31.10. Tianjin Ringpu Bio-Technology Co. Ltd.

31.11. Vetoquinol S.A.

31.12. Virbac S.A.

31.13. Zoetis Inc.

31.14. Agrolabo S.p.A.

31.15. ALS Pvt. Ltd.

32. Global Companion Animal Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Companion Animal Pharmaceuticals Market

34. Recent Developments In The Companion Animal Pharmaceuticals Market

35. Companion Animal Pharmaceuticals Market High Potential Countries, Segments and Strategies

35.1 Companion Animal Pharmaceuticals Market In 2029 - Countries Offering Most New Opportunities

35.2 Companion Animal Pharmaceuticals Market In 2029 - Segments Offering Most New Opportunities

35.3 Companion Animal Pharmaceuticals Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Dogs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Cats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Horses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Other Companion Animals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Companion Animal Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Companion Animal Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Elanco Animal Health Incorporated Financial Performance
  • Table 79: Boehringer Ingelheim International GmbH Financial Performance
  • Table 80: Ceva Santé Animale Financial Performance
  • Table 81: Chanelle Pharma Financial Performance
  • Table 82: Eco Animal Health Group PLC Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Dogs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Cats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Horses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Other Companion Animals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Companion Animal Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Companion Animal Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Elanco Animal Health Incorporated Financial Performance
  • Figure 79: Boehringer Ingelheim International GmbH Financial Performance
  • Figure 80: Ceva Santé Animale Financial Performance
  • Figure 81: Chanelle Pharma Financial Performance
  • Figure 82: Eco Animal Health Group PLC Financial Performance

Veterinary Ophthalmology Equipment Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Veterinary Ophthalmology Equipment Market Revenue Outlook: Strategic Insights and Forecast to 2029

Global Animal Antibiotics and Antimicrobials Market Projected to Reach $7.48 Billion by 2029 at a CAGR of 7.3%

Read More About Global Animal Antibiotics and Antimicrobials Market Projected to Reach $7.48 Billion by 2029 at a CAGR of 7.3%

$51.83 Billion Forecast for Animal Based Protein Supplements Market by 2029, Backed by Demand and Innovation

Read More About $51.83 Billion Forecast for Animal Based Protein Supplements Market by 2029, Backed by Demand and Innovation

Aquafeed Additives Market Forecast Reaching $2.43 Billion by 2029 at 6.9% CAGR

Read More About Aquafeed Additives Market Forecast Reaching $2.43 Billion by 2029 at 6.9% CAGR

Cattle Feed & Feed Additives Market Valuation Expected To Reach $84.77 Billion By 2029, Growing At A Rate Of 6.2%

Read More About Cattle Feed & Feed Additives Market Valuation Expected To Reach $84.77 Billion By 2029, Growing At A Rate Of 6.2%

Strong CAGR to Propel in the Companion Animal Arthritis Market and Beyond upto $6 Billion by 2029

Read More About Strong CAGR to Propel in the Companion Animal Arthritis Market and Beyond upto $6 Billion by 2029

Farm Animal Healthcare Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Read More About Farm Animal Healthcare Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Feed Binders Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Read More About Feed Binders Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Customer Communications Management Global Market Report 2025 – By Component (Solution, Services), By Deployment Mode (On-Premises, Cloud), By Organization Size (Large Enterprises, Small And Medium Enterprises), By Vertic...

View Report

Veterinary Pharmaceuticals Global Market Report 2025 – By Type (Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Veterinary Pharmaceuticals), By Type Of Animal (Livestock, Companion Animals), ...

View Report

Veterinary Pharmaceuticals Global Market Report 2025 – By Type (Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Veterinary Pharmaceuticals), By Type Of Animal (Livestock, Companion Animals), ...

View Report

Animal Medicine Global Market Report 2025 – By Medicine (Veterinary Pharmaceuticals, Feed Additives), By Type Of Animal (Companion Animal, Livestock Animals), By Type Of Prescription (OTC, Prescription), By Route Of Admi...

View Report

Cookie And Cracker Global Market Report 2025 – By Type (Cookies, Crackers), By Distribution Channel (Supermarkets Or Hypermarkets, Convenience Stores, Specialty Stores, Online Stores), By Application (Restaurants, Home, ...

View Report

Medical Equipment Rental Global Market Report 2025 – By Type (Personal Or Home Care Equipment, Electronic Or Digital Equipment, Surgical Equipment, Durable Medical Equipment, Long Term Care, Acute Care, Emergency And Tra...

View Report

Family Floater Health Insurance Global Market Report 2025 – By Coverage (In-Patient Hospitalization, Pre and Post Hospitalization Cost, Day Care Treatments, Other Coverages), By Plan Type (Immediate Family Plan, Extended...

View Report

Direct Primary Care Global Market Report 2025 – By Type (Clinical Services, Laboratory Services, Consultative Services, Care Coordination, Comprehensive Care Management), By Practice Setting (Solo Practices, Group Practi...

View Report

Frequently Asked Questions

Companion animal pharmaceuticals refer to the pharmaceutical medication process in which animal pharmacists insist on medications, fill prescriptions, and manage drug therapies for animals. It is used in the diagnosis, mitigation, and treatment of different animal diseases. For further insights on this market, request a sample here

The market major growth driver - Growing Prevalence Of Zoonotic Diseases Fuels Growth Of Companion Animal Pharmaceuticals Market. For further insights on this market, request a sample here

The companion animal pharmaceuticals market size has grown strongly in recent years. It will grow from $16.49 billion in 2024 to $17.85 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to humanization of pets, preventive healthcare measures, rise in pet insurance, changing lifestyle and urbanization, zoonotic disease concerns, zoonotic disease concerns, veterinary healthcare accessibility. The companion animal pharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $26.34 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to personalized medicine for pets, telehealth and remote veterinary services, focus on nutrition and nutraceuticals, one health initiatives, expansion of veterinary diagnostic services. Major trends in the forecast period include advancements in veterinary medicine, specialized therapeutics for aging pets, regulatory compliance and safety standards, collaborations and partnerships. For further insights on this market, request a sample here

The companion animal pharmaceuticals market covered in this report is segmented –
1) By Animal Type: Dogs, Cats, Horses, Other Companion Animals
2) By Indication: Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications
3) By Distribution Channels: Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies Subsegments:
1)By Dogs: Vaccines, Antiparasitic, Anti-Inflammatory Drugs
2) By Cats: Vaccines, Antiparasitic, Anti-Inflammatory Drugs
3) By Horses: Vaccines, Antiparasitic, Anti-Inflammatory Drugs
4) By Other Companion Animals: Vaccines, Antiparasitic, Other Therapeutics For further insights on this market, request a sample here

North America was the largest region in the companion animal pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the companion animal pharmaceuticals market report during the forecast period. The regions covered in the companion animal pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the companion animal pharmaceuticals market are Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Chanelle Pharma, Eco Animal Health Group PLC, Ashish Life Science Pvt. Ltd., Endovac Animal Health, Hipra Laboratories, Indian Immunologicals Ltd., Inovet Group, Kyoritsu Seiyaku Corporation, Lutim Pharma Pvt. Ltd., Merck & Co. Inc., Norbrook Laboratories Ltd., Tianjin Ringpu Bio-Technology Co. Ltd., Vetoquinol S.A., Virbac S.A., Zoetis Inc., Agrolabo S.p.A., ALS Pvt. Ltd., Zydus Animal Health and Investments Limited, Eli Lilly and Company, IDEXX Laboratories Inc., Merial Limited, Novartis Animal Health Inc., Dechra Pharmaceuticals PLC, Aratana Therapeutics Inc., Phibro Animal Health Corporation, Kindred Biosciences Inc., Jaguar Health Inc., Nexvet Biopharma PLC, Sentinel Biomedical Inc., PetMed Express Inc., Neogen Corporation, Heska Corporation, Synbiotics Corporation, Eurovet Animal Health B.V., Vironova AB, Abaxis Inc., Bioiberica S.A.U., Putney Inc., Lohmann Animal Health International . For further insights on this market, request a sample here.

Major trends in this market include Big Data Transforms The Companion Animal Pharmaceutical Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Companion Animal Pharmaceuticals Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon